BA
AGN

Baugh & Associates’s Allergan plc AGN Stock Holding History

Baugh & Associates’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,545
Closed -$274K – 40
2020
Q1 		$274K Buy
+1,545
New +$291K 0.26% 36

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Baugh & Associates's AGN Position: Q2 2020 in Review

Baugh & Associates sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,545 shares — an estimated $274K sold.

Baugh & Associates first reported a position in AGN in Q1 2020 and held it in 1 quarter. The position peaked at $274K in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Baugh & Associates reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Baugh & Associates sold 1,545 Allergan plc shares in Q2 2020, an estimated $274K.
  • Baugh & Associates first reported a position in Allergan plc in Q1 2020 and held it in 1 quarter.
  • Baugh & Associates's Allergan plc position peaked at $274K in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Baugh & Associates's 13F filing for Q2 2020, filed 9 Jul 2020.